Anna Olsson

624 total citations
24 papers, 459 citations indexed

About

Anna Olsson is a scholar working on Pathology and Forensic Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Anna Olsson has authored 24 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 6 papers in Rheumatology and 5 papers in Molecular Biology. Recurrent topics in Anna Olsson's work include Multiple Sclerosis Research Studies (12 papers), Medical Imaging Techniques and Applications (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Anna Olsson is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Medical Imaging Techniques and Applications (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Anna Olsson collaborates with scholars based in Denmark, Sweden and United Kingdom. Anna Olsson's co-authors include Helle Bach Søndergaard, Annette Oturai, Finn Sellebjerg, Stefan Gustavsen, Tue H. Hansen, Per Soelberg Sørensen, Annika Reynberg Langkilde, Nils Koch‐Henriksen, Henrik Ullum and Thao Duy Nguyen and has published in prestigious journals such as Frontiers in Immunology, Lara D. Veeken and Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment.

In The Last Decade

Anna Olsson

23 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Olsson Denmark 11 183 178 68 53 50 24 459
Achilles Ntranos United States 12 223 1.2× 279 1.6× 56 0.8× 24 0.5× 37 0.7× 15 556
Elaine Regina Delicato de Almeida Brazil 12 238 1.3× 100 0.6× 25 0.4× 86 1.6× 66 1.3× 24 482
Teresa Micillo Italy 12 110 0.6× 141 0.8× 83 1.2× 34 0.6× 30 0.6× 19 521
Carmela Romano Italy 10 101 0.6× 127 0.7× 35 0.5× 21 0.4× 82 1.6× 16 366
Yasunobu Hoshino Japan 11 79 0.4× 165 0.9× 47 0.7× 21 0.4× 125 2.5× 20 425
Mikhail Melnikov Russia 14 210 1.1× 127 0.7× 22 0.3× 28 0.5× 51 1.0× 47 450
Mordechai Slae Israel 10 43 0.2× 199 1.1× 90 1.3× 50 0.9× 23 0.5× 26 552
Lawrence Samkoff United States 11 162 0.9× 59 0.3× 43 0.6× 25 0.5× 134 2.7× 30 456
Daisuke Noto Japan 12 72 0.4× 332 1.9× 104 1.5× 75 1.4× 45 0.9× 20 636
Mahdi Behzad Iran 14 78 0.4× 52 0.3× 45 0.7× 32 0.6× 113 2.3× 31 448

Countries citing papers authored by Anna Olsson

Since Specialization
Citations

This map shows the geographic impact of Anna Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Olsson more than expected).

Fields of papers citing papers by Anna Olsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Olsson. The network helps show where Anna Olsson may publish in the future.

Co-authorship network of co-authors of Anna Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Olsson. A scholar is included among the top collaborators of Anna Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Olsson. Anna Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olsson, Anna, Stefan Gustavsen, Annika Reynberg Langkilde, et al.. (2025). Profiling of Epstein-Barr Virus microRNAs in Whole Blood and Exosomes in Multiple Sclerosis. Immunological Investigations. 54(8). 1524–1541.
2.
Søndergaard, Helle Bach, Anna Olsson, Stefan Gustavsen, et al.. (2024). Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis. Multiple Sclerosis and Related Disorders. 92. 106166–106166. 5 indexed citations
3.
Tornling, Göran, Charlotte Edenius, John D Pauling, et al.. (2024). A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. Lara D. Veeken. 64(2). 704–713. 5 indexed citations
4.
Petersen, Eva Rosa, Anna Olsson, Julie Laursen, et al.. (2024). Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment. Multiple Sclerosis and Related Disorders. 88. 105701–105701. 3 indexed citations
5.
Gustavsen, Stefan, Anna Olsson, Annette Oturai, et al.. (2023). The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis. European Journal of Neurology. 30(10). 3212–3220. 4 indexed citations
6.
Gustavsen, Stefan, Homayoun Roshanisefat, Matthias Kant, et al.. (2023). Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial. Pharmaceuticals. 16(8). 1079–1079. 14 indexed citations
7.
Olsson, Anna, et al.. (2023). Proteins in the Skin and Blood in Patients with Psoriasis: A Systematic Review of Proteomic Studies. Dermatology. 240(2). 317–328. 10 indexed citations
8.
Olsson, Anna, Stefan Gustavsen, Thao Duy Nguyen, et al.. (2021). Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls. Frontiers in Immunology. 12. 661493–661493. 73 indexed citations
9.
Sørensen, Per Soelberg, Tine Iskov Kopp, Hanna Joensen, et al.. (2021). Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS. Multiple Sclerosis and Related Disorders. 50. 102813–102813. 10 indexed citations
10.
Olsson, Anna, et al.. (2021). Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review. Acta Neurologica Scandinavica. 143(6). 577–586. 34 indexed citations
11.
Olsson, Anna, et al.. (2021). MRI of the Entire Spinal Cord—Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis. Diagnostics. 11(8). 1424–1424. 2 indexed citations
12.
Gustavsen, Stefan, et al.. (2021). The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. BMC Neurology. 21(1). 317–317. 41 indexed citations
13.
Olsson, Anna, Stefan Gustavsen, Annika Reynberg Langkilde, et al.. (2021). Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy. Multiple Sclerosis and Related Disorders. 54. 103136–103136. 29 indexed citations
14.
Olsson, Anna, Stefan Gustavsen, Annika Reynberg Langkilde, et al.. (2020). Biomarkers of inflammation and epithelial barrier function in multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102520–102520. 15 indexed citations
15.
Søndergaard, Helle Bach, et al.. (2018). The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(4). 2453233151–2453233151. 55 indexed citations
16.
Olsson, Anna, Annette Oturai, Helle Bach Søndergaard, Finn Sellebjerg, & Peter Oturai. (2017). Bone microarchitecture and bone mineral density in multiple sclerosis. Acta Neurologica Scandinavica. 137(3). 363–369. 9 indexed citations
17.
Olsson, Anna, et al.. (2015). Optimisation of quantitative lung SPECT applied to mild COPD: a software phantom simulation study. EJNMMI Research. 5(1). 16–16. 2 indexed citations
18.
Olsson, Anna, et al.. (2015). Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. Multiple Sclerosis Journal. 21(12). 1557–1565. 16 indexed citations
19.
Olsson, Anna, et al.. (2012). Opimization of activity level in rCBF SPECT using observer study Visual Grading Regression. 1 indexed citations
20.
Kivipelto, Miia, Alina Solomon, Kaj Blennow, Anna Olsson, & Bengt Winblad. (2006). The new cholesterol controversy - a little bit of history repeating?. Acta Neurologica Scandinavica. 114(s185). 1–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026